LCDActive
Magnetic Resonance Angiography
L34424
Effective: March 27, 2025
Updated: December 31, 2025
Policy Summary
Magnetic resonance angiography (with or without contrast) is covered when it is reasonable and necessary for the patient's diagnosis or treatment and particularly when it can replace a more invasive angiographic test and reduce patient risk. Coverage applies for arterial, venous, and lymphatic system evaluations consistent with CMS NCD Pub. 100-03, Ch.1, Pt.4, §220.2; standard MRI contraindications (e.g., implanted ferromagnetic objects or electronic devices) also apply.
Coverage Criteria Preview
Key requirements from the full policy
"MRA (with or without contrast) is covered when it can replace a more invasive diagnostic test (e."
Sign up to see full coverage criteria, indications, and limitations.